Acceder

Farmas USA

136K respuestas
Farmas USA
86 suscriptores
Farmas USA
Página
13.425 / 17.034
#107393

Re: Farmas USA

Apuntame a esa visión, si te confudes ya no te confundes solo.

 

Paciencia.
Es difícil tenerla, pero trae muy buenos resultados.....

#107394

Re: Farmas USA

SPY, 2 meses......

 

Paciencia.
Es difícil tenerla, pero trae muy buenos resultados.....

#107397

Re: Farmas USA

IBB XBI

Abstracts ASCO este miércoles

JMP: Titles to the ASCO abstracts will be released this Wednesday, April 25, and we hope there may be a positive surprise or two.

#107398

Re: Farmas USA

Se que llevas celgene. Por elliot la queda un buen rebote. Seguramente me suba a ella

#107399

Re: Farmas USA

 

Dynavax’s HEPLISAV-B ACIP recommendations published in the CDC’s MMWR

Apr. 23, 2018 7:28 AM ET|About:  Dynavax Technologies Corpo... (DVAX)|By:  Mamta Mayani, SA News Editor 

Dynavax Technologies (NASDAQ: DVAXannounces that the Centers for Disease Control and Prevention (CDC) published the Advisory Committee of Immunization Practices’ Recommendations for the use of HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for adults in the US in the Morbidity and Mortality Weekly Report (MMWR) dated April 19.

Publication in the MMWR represents the final endorsement that many policies require before reimbursement. HEPLISAV-B was commercially launched in the U.S. in January.

https://seekingalpha.com/news/3347464-dynavax-s-heplisav-b-acip-recommendations-published-cdc-s-mmwr